missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PLAA Polyclonal Antibody, Invitrogen™
Description
Phospholipase A-2-activating protein (PLAA), also named PLAP, can interact with ubiquitin and is involved in the maintenance of ubiquitin levels. PLAA contains multiple consensus domains including WD repeats, PFU domain and PUL domain. Although the function of PLAA remains unclear, ubiquitin binding of PLAA might be the central role that connects ubiquitination and degradation in ERAD. Recent finding revealed that PLAA served as a novel nociceptive mediator after incision, and its expression level is regulated by miR-203.
Specifications
Specifications
| Antigen | PLAA |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 |
| Gene | Plaa |
| Gene Accession No. | Q9Y263 |
| Gene Alias | 2410007N06; AI536418; AU018445; AW208417; D4Ertd618e; DOA1; DOA1 homolog; phospholipase A2 activating protein; phospholipase A2, activating protein; phospholipase A-2-activating protein; phospholipase A2-activating protein; PLA2P; Plaa; PLAP; Ufd3 |
| Gene Symbols | Plaa |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?